Clinical and genetic heterogeneity in multifocal vitelliform dystrophy

Archives of Ophthalmology

Volumn 125, Issue 8, 2007, Pages 1100-1106

  Boon, Camiel J F ^a   Klevering, Jeroen ^a   Den Hollander, Anneke I ^a,b   Zonneveld, Marijke N ^a   Theelen, Thomas ^a   Cremers, Frans P M ^a,b   Hoyng, Carel B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PERIPHERIN;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DNA DETERMINATION; EYE EXAMINATION; FEMALE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA VITELLIFORM DEGENERATION; SCREENING TEST; VMD2 GENE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHLORIDE CHANNELS; DISEASE PROGRESSION; DNA; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; OPHTHALMOSCOPY; PIGMENT EPITHELIUM OF EYE; POLYMERASE CHAIN REACTION; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETINAL DEGENERATION; VISUAL ACUITY;

EID: 34547876791     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.8.1100     Document Type: Article

References (40)

1. Caumon C, Bernard JA, Mondon H, Quentel G, Hamard H, Chevaleraud J. Multifocal vitelliform dystrophy: a case report [in French; author's translation]. J Fr Ophtalmol. 1981;4(4):279-285.
2. Denden A, Littann KE. On late symptoms of the multiple vitelliform retina cysts [in German]. Ophthalmologica. 1972;164(2):84-96.
3. Denden A, Littann KE. Fluorescent angiography in multiple vitelliform retinal cysts of the posterior ocular pole [in German]. Ophthalmologica. 1973;166(2):94-104.
4. Godel V, Chaine G, Regenbogen L, Lazar M. Hereditary vitelliform macular dystrophy. Aust N Z J Ophthalmol. 1986;14(3):221-228.
5. Hittner HM, Ferrell RE, Borda RP, Justice J Jr. Atypical vitelliform macular dystrophy in a 5-generation family. Br J Ophthalmol. 1984;68(3):199-207.
6. Laatikainen L. Presumed vitelliform dystrophy with perimacular flecks and retinal detachment. Int Ophthalmol. 1979;1(3):163-170.
7. Laloum JE, Deutman AF. Peripheral vitelliform lesions in vitelliform macular dystrophy [in French]. J Fr Ophtalmol. 1991;14(2):74-78.
8. Lisch W, Weidle EG, Richard G, Thiel HJ. Multiple vitelliform retinal cysts: case report and review of the literature [in German]. Klin Monatsbl Augenheilkd. 1989;194(2):120-128.
9. Littann KE. Multiple vitelliform cysts of the retina [in German]. Ber Zusammenkunft Dtsch Ophthalmol Ges. 1966;67:442-446.
10. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol. 1977;95(6):984-990.
11. Mullins RF, Oh KT, Heffron E, Hageman GS, Stone EM. Late development of vitelliform lesions and flecks in a patient with Best disease: clinicopathologic correlation. Arch Ophthalmol. 2005;123(11):1588-1594.
12. Pece A, Gaspari G, Avanza P, Magni R, Brancato R. Best's multiple vitelliform degeneration. Int Ophthalmol. 1992;16(6):459-464.
13. Remky H, Kolbl I. Multiple vitelliform cysts [in German]. Klin Monatsbl Augenheilkd. 1971;159(3):322-330.
14. Renner AB, Tillack H, Kraus H, et al. Late onset is common in Best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005;112(4):586-592.
15. Shibuya Y, Hayasaka S. Various fundus manifestations in a Japanese family with Best's vitelliform macular dystrophy. Jpn J Ophthalmol. 1993;37(4):478-484.
16. Walter P, Brunner R, Heimann K. Atypical presentations of Best's vitelliform macular degeneration: clinical findings in seven cases. Ger J Ophthalmol. 1994;3(6):440-444.
17. Krämer F, White K, Pauleikhoff D, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000;8(4):286-292.
18. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in Best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41(6):1291-1296.
19. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19(3):241-247.
20. Pollack K, Kreuz FR, Pillunat LE. Best's disease with normal EOG: case report of familial macular dystrophy [in German]. Ophthalmologe. 2005;102(9):891-894.
21. Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1453-1466.
22. Renner AB, Tillack H, Kraus H, et al. Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina. 2004;24(6):929-939.
23. Gass JD. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol 1. 4th ed. St Louis, MO: Mosby-Year Book Inc; 1997:314-325.
24. Seddon JM, Afshari MA, Sharma S, et al. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology. 2001;108(11):2060-2067.
25. Zhuk SA, Edwards AO. Peripherin/RDS and VMD2 mutations in macular dystrophies with adult-onset vitelliform lesion. Mol Vis. 2006;12:811-815.
26. Thijssen JM, Pinckers A, Otto AJ. A multipurpose optical system for ophthalmic electrodiagnosis. Ophthalmologica. 1974;168(4):308-314.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
28. Marquardt A, Stohr H, Passmore LA, Kramer F, Rivera A, Weber BH. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenileonset vitelliform macular dystrophy (Best's disease). Hum Mol Genet. 1998;7(9):1517-1525.
29. van Lith-Verhoeven JJ, Cremers FP, van den Helm B, Hoyng CB, Deutman AF. Genetic heterogeneity of butterfly-shaped pigment dystrophy of the fovea. Mol Vis. 2003;9:138-143.
30. Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein: functional implications. Hum Genet. 1999;104(5):383-389.
31. Krämer F, Mohr N, Kellner U, Rudolph G, Weber BH. Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD). Hum Mutat. 2003;22(5):418-424.
32. Chan CK, Gass JD, Lin SG. Acute exudative polymorphous vitelliform maculopathy syndrome. Retina. 2003;23(4):453-462.
33. Roberts DK, Haine CL. Idiopathic multiple serous detachments of the retinal pigment epithelium: a report of two cases. J Am Optom Assoc. 1991;62(6):464-471.
34. Marmorstein AD, Kinnick TR. Focus on molecules: bestrophin (Best-1) [published online ahead of print March 23, 2006]. Exp Eye Res. doi:10.1016/j.exer.2006.03.021.
35. Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology. 2006;113(8):1392-1400.
36. Maruko I, Iida T, Spaide RF, Kishi S. Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy. Am J Ophthalmol. 2006;141(5):976-978.
37. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100(7):1115-1121.
38. O'Gorman S, Flaherty WA, Fishman GA, Berson EL. Histopathologic findings in Best's vitelliform macular dystrophy. Arch Ophthalmol. 1988;106(9):1261-1268.
39. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 1982;100(7):1108-1114.
40. Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea: detection of the carrier state. Arch Ophthalmol. 1969;81(3):305-316.